Alglucerase injection is as an enzyme replacement therapy in patients diagnosed with type I Gaucher’s disease, a genetic disorder with symptoms and signs of anemia or bleeding tendency, liver disorder, and bone disease.
This medication is an enzyme, prescribed as an adjuvant in subcutaneous fluid administration for achieving hydration, dispersion and absorption of other injected drugs, and improving resorption of radiopaque agents.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer